BAM Set to Confirm Chong Wei's B Sample Doping Test Positive

BAM Prepares Announcement on Chong Wei B Sample Result

The Badminton Association of Malaysia (BAM) is expected to formally announce that the B sample taken from national icon Lee Chong Wei has tested positive for a banned substance, according to a report by NST Online. The announcement would confirm what the A sample had already indicated, leaving the three-time Olympic silver medalist facing a potentially career-ending situation.

The B sample result is a critical step in the anti-doping process. Under World Anti-Doping Agency (WADA) rules, an athlete has the right to request analysis of their B sample after an A sample returns a positive finding. If the B sample also tests positive, the adverse analytical finding is considered confirmed, and formal disciplinary proceedings can begin.

Chong Wei, widely regarded as Malaysia's greatest-ever badminton player, had been under scrutiny after his A sample flagged a prohibited substance. The specific substance linked to the case is dextamethasone, a corticosteroid banned in competition under the WADA prohibited list.

What a Confirmed Positive Means for Chong Wei

A confirmed B sample positive puts Chong Wei at serious risk of a suspension that could end his professional career. At the time the case emerged, he was ranked world number one and had spent a record number of weeks at the top of the BWF rankings. Any ban of significant length would almost certainly rule out his participation in future major tournaments, including the Olympics.

BAM had previously expressed support for Chong Wei and pledged to help him through the process. The association's expected announcement signals that internal discussions have progressed to a point where a public statement can no longer be delayed.

The Badminton World Federation (BWF) oversees doping cases for the sport, and once BAM makes its official statement, the matter moves firmly into BWF's jurisdiction for adjudication.

Background on the Case

Chong Wei's doping case first came to light after a sample collected during a competition returned an adverse finding. The news sent shockwaves through Malaysian sport, where he holds near-legendary status. He had represented the country across multiple Olympic Games and was a dominant force on the world tour for well over a decade.

The substance flagged, dextamethasone, is a glucocorticoid used medically to treat inflammation and other conditions. Its use is prohibited in competition under the WADA code unless the athlete holds a valid Therapeutic Use Exemption (TUE). Whether Chong Wei held such an exemption was a central question in the early stages of the case.

His legal and support team had maintained that there was an explanation for the finding, and the B sample request was a standard move to verify or challenge the initial result. With the B sample now also reported as positive, that avenue of challenge appears to have closed.

Reaction and What Comes Next

The expected BAM announcement has been anticipated for some time, with media and fans closely monitoring developments. NST Online, which first reported the expectation of the announcement, noted the significance of the timing as all parties appeared ready to move forward with formal proceedings.

Once the official confirmation is made public, a hearing process will follow. Chong Wei would have the opportunity to present his case before a disciplinary panel, where factors such as the source of the substance, intent, and any applicable TUE documentation would be examined. Sanctions can range from a formal warning to a multi-year ban depending on the findings.

For Malaysian badminton, the outcome carries weight well beyond one player's career. Chong Wei has been the face of the sport in the country for years, and the case has prompted wider conversations about athlete welfare, supplement safety, and the support structures surrounding elite competitors.